ADAR1 Capital Management »

Irhythm Technologies shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Irhythm Technologies (IRTC) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Irhythm Technologies

Tip: Access up to 7 years of quarterly data

All positions including Irhythm Technologies held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Irhythm Technologies by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $357k 3.0k 118.95

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Irhythm Technologies

BlackRock
Rtw Investments
Vanguard Portfolio Management
Artisan Partners Limited Partnership
Vanguard Capital Management
Millennium Management
FMR
Ubs Global Asset Management Americas
Geode Capital Management
Eventide Asset Management
Bnp Paribas Investment Partners
State Street Corporation
Holocene Advisors
Jpmorgan Chase & Co
Stephens Investment Management Group

View all funds holding Irhythm Technologies